 |
Prescription and Over-the-Counter Drug Product List - 22nd Edition
Cumulative Supplement Number 3: March 2002
NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section CUMULATIVE SUPPLEMENT LEGEND.
ALBUTEROL SULFATE
AEROSOL, METERED; INHALATION
PROVENTIL-HFA
>D> + 3M EQ 0.09MG BASE/INH N20503 001 AUG 15, 1996 MAR CTEC
>A> BX + EQ 0.09MG BASE/INH N20503 001 AUG 15, 1996 MAR CTEC
VENTOLIN HFA
>D> + GLAXOSMITHKLINE EQ 0.09MG BASE/INH N20983 001 APR 19, 2001 MAR CTEC
>A> BX + EQ 0.09MG BASE/INH N20983 001 APR 19, 2001 MAR CTEC
AMOXICILLIN; CLAVULANATE POTASSIUM
TABLET; ORAL
>A> AMOXICILLIN AND CLAVULANATE POTASSIUM
>A> AB GENEVA PHARMS 500MG;EQ 125MG BASE N65064 001 MAR 15, 2002 MAR NEWA
>A> AB 875MG;EQ 125MG BASE N65063 001 MAR 14, 2002 MAR NEWA
>A> AUGMENTIN '500'
>D> GLAXOSMITHKLINE 500MG;EQ 125MG BASE N50564 002 AUG 06, 1984 MAR CFTG
>A> AB 500MG;EQ 125MG BASE N50564 002 AUG 06, 1984 MAR CFTG
>A> AUGMENTIN '875'
>D> + GLAXOSMITHKLINE 875MG;EQ 125MG BASE N50720 001 FEB 13, 1996 MAR CFTG
>A> AB + 875MG;EQ 125MG BASE N50720 001 FEB 13, 1996 MAR CFTG
AMPICILLIN SODIUM; SULBACTAM SODIUM
INJECTABLE; INJECTION
>A> AMPICILLIN AND SULBACTAM
>A> AP ESI LEDERLE EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL N65074 001 MAR 19, 2002 MAR NEWA
>A> AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL N65074 002 MAR 19, 2002 MAR NEWA
>A> AP EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL N65076 001 MAR 19, 2002 MAR NEWA
>A> UNASYN
>D> + PFIZER EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL N50608 002 DEC 31, 1986 MAR CFTG
>A> AP + EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL N50608 002 DEC 31, 1986 MAR CFTG
>D> + EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL N50608 001 DEC 31, 1986 MAR CFTG
>A> AP + EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL N50608 001 DEC 31, 1986 MAR CFTG
>D> + EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL N50608 005 DEC 10, 1993 MAR CFTG
>A> AP + EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL N50608 005 DEC 10, 1993 MAR CFTG
BENZONATATE
CAPSULE; ORAL
TESSALON
>A> + FOREST LABS 200MG N11210 003 JUN 25, 1999 MAR NEWA
BUSPIRONE HYDROCHLORIDE
TABLET; ORAL
BUSPIRONE HCL
>A> AB EGIS 5MG N75119 001 MAR 14, 2002 MAR NEWA
>A> AB 10MG N75119 002 MAR 14, 2002 MAR NEWA
>A> AB GENEVA PHARMS 5MG N75413 001 MAR 19, 2002 MAR NEWA
>A> AB 10MG N75413 002 MAR 19, 2002 MAR NEWA
>A> AB 15MG N75413 003 MAR 19, 2002 MAR NEWA
>A> AB MYLAN 5MG N75272 001 MAR 01, 2002 MAR NEWA
>A> AB 10MG N75272 002 MAR 01, 2002 MAR NEWA
>A> AB ZENITH GOLDLINE 5MG N75385 001 MAR 01, 2002 MAR NEWA
>A> AB 10MG N75385 002 MAR 01, 2002 MAR NEWA
>A> AB 15MG N75385 003 MAR 01, 2002 MAR NEWA
BUTORPHANOL TARTRATE
SPRAY, METERED; NASAL
BUTORPHANOL TARTRATE
>A> AB ROXANE 1MG/SPRAY N75824 001 MAR 12, 2002 MAR NEWA
CLADRIBINE
INJECTABLE; INJECTION
LEUSTATIN
>D> + JOHNSON RW 1MG/ML N20229 001 FEB 26, 1993 MAR CAHN
>A> + ORTHO BIOTECH 1MG/ML N20229 001 FEB 26, 1993 MAR CAHN
DESONIDE
LOTION; TOPICAL
DESONIDE
>A> AB ALTANA 0.05% N75860 001 MAR 19, 2002 MAR NEWA
DESOWEN
>D> + GALDERMA LABS LP 0.05% N72354 001 JAN 24, 1992 MAR CFTG
>A> AB + 0.05% N72354 001 JAN 24, 1992 MAR CFTG
ERYTHROMYCIN
GEL; TOPICAL
>A> E-GLADES
>A> AT GLADES PHARMS 2% N65009 001 MAR 18, 2002 MAR NEWA
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET; ORAL-21
ALESSE
>D> AB1 + WYETH AYERST 0.02MG;0.1MG N20683 001 MAR 27, 1997 MAR CTEC
>A> AB + 0.02MG;0.1MG N20683 001 MAR 27, 1997 MAR CTEC
AVIANE-21
>D> AB DURAMED PHARM BARR 0.02MG;0.1MG N75796 002 APR 30, 2001 MAR CTEC
>A> AB1 0.02MG;0.1MG N75796 002 APR 30, 2001 MAR CTEC
LESSINA-21
>A> AB2 BARR 0.02MG;0.1MG N75803 001 MAR 20, 2002 MAR NEWA
LEVLITE
>D> BX + BERLEX LABS 0.02MG;0.1MG N20860 001 JUL 13, 1998 MAR CTEC
>A> AB2 + 0.02MG;0.1MG N20860 001 JUL 13, 1998 MAR CTEC
TABLET; ORAL-28
ALESSE
>D> AB WYETH AYERST 0.02MG;0.1MG N20683 002 MAR 27, 1997 MAR CTEC
>A> AB1 0.02MG;0.1MG N20683 002 MAR 27, 1997 MAR CTEC
AVIANE-28
>D> AB1 DURAMED PHARM BARR 0.02MG;0.1MG N75796 001 APR 30, 2001 MAR CTEC
>A> AB1 0.02MG;0.1MG N75796 001 APR 30, 2001 MAR CTEC
LESSINA-28
>A> AB BARR 0.02MG;0.1MG N75803 002 MAR 20, 2002 MAR NEWA
LEVLITE
>D> BX BERLEX LABS 0.02MG;0.1MG N20860 002 JUL 13, 1998 MAR CTEC
>A> AB 0.02MG;0.1MG N20860 002 JUL 13, 1998 MAR CTEC
FAMOTIDINE
INJECTABLE; INJECTION
FAMOTIDINE
>D> @ APOTHECON 10MG/ML N75707 001 APR 16, 2001 MAR MAGC
>A> @ 10MG/ML N75707 001 APR 16, 2001 MAR MAGC
FAMOTIDINE PRESERVATIVE FREE
>D> @ APOTHECON 10MG/ML N75708 001 APR 16, 2001 MAR WDAG
>A> @ 10MG/ML N75708 001 APR 16, 2001 MAR WDAG
FLUDROCORTISONE ACETATE
TABLET; ORAL
>A> FLORINEF
>D> + KING PHARMS 0.1MG N10060 001 AUG 18, 1955 MAR CFTG
>A> AB + 0.1MG N10060 001 AUG 18, 1955 MAR CFTG
>A> FLUDROCORTISONE ACETATE
>A> AB IMPAX LABS 0.1MG N40431 001 MAR 18, 2002 MAR NEWA
HYDROCHLOROTHIAZIDE
TABLET; ORAL
ESIDRIX
>D> AB NOVARTIS 100MG N11793 009 AUG 31, 1976 MAR CRLD
>A> AB + 100MG N11793 009 AUG 31, 1976 MAR CRLD
HYDROCHLOROTHIAZIDE
>A> AB VINTAGE PHARMS 25MG N40412 001 MAR 29, 2002 MAR NEWA
>A> AB 50MG N40412 002 MAR 29, 2002 MAR NEWA
HYDRODIURIL
>D> AB MERCK 25MG N11835 003 AUG 22, 1963 MAR DISC
>A> @ 25MG N11835 003 AUG 22, 1963 MAR DISC
>D> AB + 50MG N11835 006 AUG 22, 1963 MAR DISC
>A> @ 50MG N11835 006 AUG 22, 1963 MAR DISC
>D> AB 100MG N11835 007 JAN 01, 1975 MAR DISC
>A> @ 100MG N11835 007 JAN 01, 1975 MAR DISC
HYDROCORTISONE ACETATE
CREAM; TOPICAL
MICORT-HC
>A> + FERNDALE LABS 2% N40398 001 MAR 29, 2002 MAR NEWA
HYDROCORTISONE BUTYRATE
CREAM; TOPICAL
LOCOID
>A> + FERNDALE LABS 0.1% N18514 001 MAR 31, 1982 MAR CAHN
>D> + YAMANOUCHI 0.1% N18514 001 MAR 31, 1982 MAR CAHN
LOCOID LIPOCREAM
>A> + FERNDALE LABS 0.1% N20769 001 SEP 08, 1997 MAR CAHN
>D> + YAMANOUCHI 0.1% N20769 001 SEP 08, 1997 MAR CAHN
OINTMENT; TOPICAL
LOCOID
>A> + FERNDALE LABS 0.1% N18652 001 OCT 29, 1982 MAR CAHN
>D> + YAMANOUCHI 0.1% N18652 001 OCT 29, 1982 MAR CAHN
LAMOTRIGINE
TABLET, CHEWABLE; ORAL
LAMICTAL CD
>D> GLAXOSMITHKLINE 25MG N20764 002 AUG 24, 1998 MAR CRLD
>A> + 25MG N20764 002 AUG 24, 1998 MAR CRLD
>D> + 100MG N20764 003 AUG 24, 1998 MAR DISC
>A> @ 100MG N20764 003 AUG 24, 1998 MAR DISC
LEVOTHYROXINE SODIUM
TABLET; ORAL
>A> LEVO-T
>A> BX MOVA 0.025MG N21342 001 MAR 01, 2002 MAR NEWA
>A> BX 0.05MG N21342 002 MAR 01, 2002 MAR NEWA
>A> BX 0.075MG N21342 003 MAR 01, 2002 MAR NEWA
>A> BX 0.088MG N21342 004 MAR 01, 2002 MAR NEWA
>A> BX 0.1MG N21342 005 MAR 01, 2002 MAR NEWA
>A> BX 0.112MG N21342 006 MAR 01, 2002 MAR NEWA
>A> BX 0.125MG N21342 007 MAR 01, 2002 MAR NEWA
>A> BX 0.15MG N21342 008 MAR 01, 2002 MAR NEWA
>A> BX 0.175MG N21342 009 MAR 01, 2002 MAR NEWA
>A> BX 0.2MG N21342 010 MAR 01, 2002 MAR NEWA
>A> BX + 0.3MG N21342 011 MAR 01, 2002 MAR NEWA
MESNA
INJECTABLE; INTRAVENOUS
>A> MESNEX
>D> AP + ASTA 100MG/ML N19884 001 DEC 30, 1988 MAR CAHN
>A> AP + BAXTER HLTHCARE 100MG/ML N19884 001 DEC 30, 1988 MAR CAHN
>A> TABLET; ORAL
>A> + BRISTOL MYERS SQUIBB 400MG N20855 001 MAR 21, 2002 MAR NEWA
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION
>A> MIDAZOLAM HCL
>D> @ APOTHECON EQ 1MG BASE/ML N75620 001 NOV 01, 2000 MAR MAGC
>A> @ EQ 1MG BASE/ML N75620 001 NOV 01, 2000 MAR MAGC
>D> @ EQ 5MG BASE/ML N75620 002 NOV 01, 2000 MAR MAGC
>A> @ EQ 5MG BASE/ML N75620 002 NOV 01, 2000 MAR MAGC
>D> @ EQ 5MG BASE/ML N75641 001 OCT 19, 2000 MAR MAGC
>A> @ EQ 5MG BASE/ML N75641 001 OCT 19, 2000 MAR MAGC
>D> @ ASTRAZENECA EQ 5MG BASE/ML N75263 001 JUN 26, 2000 MAR MAGC
>A> @ EQ 5MG BASE/ML N75263 001 JUN 26, 2000 MAR MAGC
SYRUP; ORAL
>A> AA RANBAXY EQ 2MG BASE/ML N76058 001 MAR 15, 2002 MAR NEWA
>A> VERSED
>D> + ROCHE EQ 2MG BASE/ML N20942 001 OCT 15, 1998 MAR CFTG
>A> AA + EQ 2MG BASE/ML N20942 001 OCT 15, 1998 MAR CFTG
MOMETASONE FUROATE
OINTMENT; TOPICAL
ELOCON
>D> + SCHERING 0.1% N19543 001 APR 30, 1987 MAR CFTG
>A> AB + 0.1% N19543 001 APR 30, 1987 MAR CFTG
MOMETASONE FUROATE
>A> AB CLAY PARK 0.1% N76067 001 MAR 18, 2002 MAR NEWA
MORPHINE SULFATE
CAPSULE, EXTENDED RELEASE; ORAL
>A> AVINZA
>A> ELAN PHARM 30MG N21260 001 MAR 20, 2002 MAR NEWA
>A> 60MG N21260 002 MAR 20, 2002 MAR NEWA
>A> 90MG N21260 003 MAR 20, 2002 MAR NEWA
>A> + 120MG N21260 004 MAR 20, 2002 MAR NEWA
NALTREXONE HYDROCHLORIDE
TABLET; ORAL
NALTREXONE HCL
>A> MALLINCKRODT 25MG N76264 001 MAR 22, 2002 MAR NEWA
>A> AB 50MG N76264 002 MAR 22, 2002 MAR NEWA
>A> + 100MG N76264 003 MAR 22, 2002 MAR NEWA
NISOLDIPINE
TABLET, EXTENDED RELEASE; ORAL
SULAR
>A> + FIRST HORIZON 10MG N20356 001 FEB 02, 1995 MAR CAHN
>A> 20MG N20356 002 FEB 02, 1995 MAR CAHN
>A> + 30MG N20356 003 FEB 02, 1995 MAR CAHN
>A> + 40MG N20356 004 FEB 02, 1995 MAR CAHN
>D> + WHITEHALL ROBINS 10MG N20356 001 FEB 02, 1995 MAR CAHN
>D> 20MG N20356 002 FEB 02, 1995 MAR CAHN
>D> + 30MG N20356 003 FEB 02, 1995 MAR CAHN
>D> + 40MG N20356 004 FEB 02, 1995 MAR CAHN
PAMIDRONATE DISODIUM
>A> INJECTABLE; IV (INFUSION)
>A> PAMIDRONATE DISODIUM
>A> AP BEDFORD EQ 30MG /10ML(3MG/ML) N21113 001 MAR 04, 2002 MAR NEWA
>A> AP + EQ 90MG /10ML(9MG/ML) N21113 002 MAR 04, 2002 MAR NEWA
>A> AP GENSIA SICOR PHARMS EQ 30MG /10ML(3MG/ML) N76153 001 MAR 27, 2002 MAR NEWA
>A> AP EQ 90MG /10ML(9MG/ML) N76153 002 MAR 27, 2002 MAR NEWA
PHENDIMETRAZINE TARTRATE
TABLET; ORAL
PHENDIMETRAZINE TARTRATE
>D> @ MIKART 35MG N89452 001 OCT 30, 1991 MAR CMFD
>A> AA 35MG N89452 001 OCT 30, 1991 MAR CMFD
PRAVASTATIN SODIUM
TABLET; INJECTION
PRAVACHOL
>A> + BRISTOL MYERS SQUIBB 80MG N19898 008 DEC 18, 2001 MAR NEWA
TABLET; ORAL
>D> + BRISTOL MYERS SQUIBB 40MG N19898 004 MAR 22, 1993 MAR CRLD
>A> 40MG N19898 004 MAR 22, 1993 MAR CRLD
VALACYCLOVIR HYDROCHLORIDE
TABLET; ORAL
VALTREX
>D> + GLAXOSMITHKLINE EQ 500MG BASE N20487 001 JUN 23, 1995 MAR DISC
>A> @ EQ 500MG BASE N20487 001 JUN 23, 1995 MAR DISC
>D> @ EQ 1GM BASE N20487 002 JUN 23, 1995 MAR DISC
>A> @ EQ 1GM BASE N20487 002 JUN 23, 1995 MAR DISC
ACETAMINOPHEN
TABLET, EXTENDED RELEASE; ORAL
ACETAMINOPHEN
>A> COREPHARMA 650MG N76200 001 MAR 19, 2002 MAR NEWA
FAMOTIDINE
TABLET; ORAL
FAMOTIDINE
>A> TORPHARM 10MG N75610 001 MAR 12, 2002 MAR NEWA
IBUPROFEN
TABLET; ORAL
IBUPROFEN
>A> PERRIGO 200MG N75995 001 MAR 14, 2002 MAR NEWA
MINOXIDIL
SOLUTION; TOPICAL
MINOXIDIL EXTRA STRENGTH (FOR MEN)
>A> CLAY PARK 5% N75737 001 MAR 15, 2002 MAR NEWA
>D> NOVEX 5% N75839 001 OCT 01, 2001 MAR CTNA
>A> 5% N75839 001 OCT 01, 2001 MAR CTNA
Last update: July 15, 2005 |
|
